id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-E-0073-0007,FDA,FDA-1998-E-0073,Letter from FDA/CDER to US Patent and Trademark Office,Other,Letter(s),2003-11-21T05:00:00Z,2003,11,,,2025-03-05T18:21:25Z,,0,0,0900006480583e36
FDA-1998-E-0073-0006,FDA,FDA-1998-E-0073,Determination of Regulatory Review Period for Purposes of Patent Extension; Vitreon; Amendment,Notice,General Notice,2003-03-18T05:00:00Z,2003,3,,,2025-03-05T18:20:06Z,03-6226,0,0,0900006480583e35